| GBP millions | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | Trend | YoY |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Cost of revenue | 0.6 | 0.2 | 0.6 | 0.2 | 0.0 | 0.0 | −92.4% | |
| Gross profit | (0.6) | (0.2) | (0.6) | (0.2) | (0.0) | (0.0) | +92.4% | |
| Research & development | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Selling, general & administrative | 1.5 | 1.1 | 1.5 | 1.0 | 2.3 | 1.3 | −41.3% | |
| Selling & marketing | 0.0 | 0.0 | 0.6 | 0.0 | 0.0 | 0.0 | — | |
| Operating expenses | 2.5 | 2.7 | (0.5) | 2.0 | 9.6 | 33.1 | +243.4% | |
| Operating income | (2.5) | (2.9) | (0.1) | (2.2) | (9.7) | (33.1) | −242.2% | |
| Interest expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | +967.8% | |
| Interest income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Other income / expense | 0.0 | 0.2 | 1.8 | 0.3 | 0.1 | (0.0) | −115.4% | |
| Pre-tax income | (2.5) | (2.7) | 1.7 | (1.9) | (9.6) | (33.1) | −246.5% | |
| Income tax | (0.2) | 0.0 | 0.0 | (0.1) | 0.0 | 0.0 | — | |
| Net income | (2.3) | (2.7) | 1.7 | (1.8) | (9.6) | (33.1) | −246.5% | |
| Discontinued operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Other net income adjustments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| EPS, basic (per share) | (0.00) | (0.00) | 0.00 | (0.00) | (0.01) | (0.01) | −40.4% | |
| EPS, diluted (per share) | (0.00) | (0.00) | 0.00 | (0.00) | (0.01) | (0.01) | −40.4% | |
| EBITDA | (1.9) | (2.2) | (2.1) | (1.5) | (2.9) | (2.9) | −3.1% | |
| Depreciation & amortization | 0.6 | 0.5 | 0.4 | 0.3 | 5.2 | 0.2 | −95.7% | |
| Weighted average shares (shares) | 970,205,253 | 971,659,743 | 1,032,448,213 | 1,117,083,397 | 1,665,171,000 | 4,121,037,667 | +147.5% | |
| Weighted average diluted shares (shares) | 970,205,253 | 971,659,743 | 1,032,448,213 | 1,117,083,397 | 1,664,901,000 | 4,121,037,667 | +147.5% |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
